FDG PET/CT to predict pathologic complete response to neoadjuvant systemic treatment in breast and axilla in triple negative and in HER2-positive breast cancer

Van Ramshorst, M., Teixeira, S., Pengel, K., Gilhuijs, K., Olmos, R. Valdes, Rodenhuis, S., Rutgers, E., Vogel, W., Sonke, G., Peeters, M. J. Vrancken

European Journal of Cancer 57 p. S95-S96